24 Nov 2025 | 3 Mins Read
Tatva Chintan Pharma Chem target at Rs 1380
Flipitmoney
Tatva Chintan Pharma Chemicals delivered a strong Q2 FY26 performance with 6% QoQ and 48% YoY revenue growth to INR 1,235 mn. EBITDA rose 28% QoQ and 298% YoY to INR 222 mn driven by higher volumes in SDA and gross margin expansion. Structure Directing Agents segment revenue rose 51% QoQ and 119% YoY.